Growth Metrics

Iradimed (IRMD) Current Leases (2019 - 2025)

Iradimed (IRMD) reported Current Leases of $59221.0 for Q1 2025, down 85.86% year-over-year from $418814.0 in Q1 2024, and down 61.36% on a QoQ basis from $153264.0 in Q4 2024.

Iradimed (IRMD) has 7 years of Current Leases data on file, last reported at $59221.0 in Q1 2025.

  • Quarterly Current Leases fell 85.86% year-over-year to $59221.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $59221.0 (down 85.86% YoY) and the FY2024 annual result came in at $153264.0, down 64.19% from the prior year.
  • Current Leases retreated to $59221.0 in Q1 2025 per IRMD's latest filing, from $153264.0 in the prior quarter.
  • Across five years, Current Leases topped out at $427963.0 in Q4 2023 and bottomed at $59221.0 in Q1 2025.
  • The 5-year median for Current Leases is $284891.0 (2022), against an average of $303403.1.
  • The widest annual swing landed in 2023, when Current Leases soared 45.83%; it then tumbled 85.86% in 2025.
  • Tracing IRMD's Current Leases over 5 years: stood at $276568.0 in 2021, then increased by 6.11% to $293466.0 in 2022, then soared by 45.83% to $427963.0 in 2023, then tumbled by 64.19% to $153264.0 in 2024, then plunged by 61.36% to $59221.0 in 2025.
  • Per Business Quant, the three latest IRMD Current Leases figures stand at $59221.0 (Q1 2025), $153264.0 (Q4 2024), and $261244.0 (Q3 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 24.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 20.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 35.80 Mn
10 Iradimed 1.17 Bn 1.11 Bn 16.81 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2025 59,221.00
Dec 31, 2024 153,264.00
Sep 30, 2024 261,244.00
Jun 30, 2024 367,618.00
Mar 31, 2024 418,814.00
Dec 31, 2023 427,963.00
Sep 30, 2023 421,379.00
Jun 30, 2023 413,745.00
Mar 31, 2023 409,295.00
Dec 31, 2022 293,466.00
Sep 30, 2022 289,147.00
Jun 30, 2022 284,891.00
Mar 31, 2022 280,698.00
Dec 31, 2021 276,568.00
Sep 30, 2021 272,498.00
Jun 30, 2021 268,488.00
Mar 31, 2021 259,553.00
Dec 31, 2020 255,698.00
Sep 30, 2020 251,901.00
Jun 30, 2020 248,159.00
Mar 31, 2020 244,474.00
Dec 31, 2019 240,843.00
Sep 30, 2019 237,266.00
Jun 30, 2019 233,743.00
Mar 31, 2019 230,271.00